A bracelet that continuously measures your temperature and breathing and thus detects any symptoms of COVID-19 at an early stage. To that end, Rick Grobbee, professor of clinical epidemiology at UMC Utrecht and his team, will test an existing wearable among 40,000 people. For this, he has received a subsidy of ten million euros from the European Innovative Medicines Initiative (IMI).
This wearable has been developed by Ava AG (Switzerland) for women to measure when they are ovulating, so that they know when they are fertile. The wearable does this by very accurately measuring the temperature, respiration and skin moisture. This is already a certified device.